Beta Bionics, Inc. Common Stock (BBNX) — Financial Flexibility Index
Beta Bionics, Inc. Common Stock (BBNX) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of $-7.45 Million (operating CF $-8.73 Million minus capex $1.28 Million) represents 0% of total liabilities ($35.29 Million). Also explore Beta Bionics, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beta Bionics, Inc. Common Stock Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Beta Bionics, Inc. Common Stock across 3 annual periods. Check how strategically is Beta Bionics, Inc. Common Stock's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Beta Bionics, Inc. Common Stock (2022–2024)
Year-by-year free cash flow to debt coverage for Beta Bionics, Inc. Common Stock. For the full company profile including market capitalisation, see how much is Beta Bionics, Inc. Common Stock worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.61x | $-44.88 Million | $-48.27 Million | $73.63 Million | ▲ +2.2% |
| 2023 | -0.62x | $-32.04 Million | $-32.45 Million | $51.43 Million | ▲ +76.4% |
| 2022 | -2.64x | $-59.44 Million | $-60.21 Million | $22.53 Million | — |